RSS

Tag Archives: Globocan 2008

A Cancer You Can Prevent

Colon cancer is one of the most common worldwide, and is strongly linked to lifestyle choices

A 42-year-old Delhi-based MCD official ignored rectal bleeding for almost a year. He also overlooked unexplained weight loss, and the fact that he was fatigued all the time. Finally, he was referred by his doctor for a colonoscopy. The test revealed a tumour, which was found to be cancerous.

Colon cancer is on the increase“My patient couldn’t believe that he has been diagnosed with colorectal cancer (CRC), commonly known as colon cancer or bowel cancer. He kept asking, ‘Why me? I have always been very fit and healthy’,” says Shyam Aggarwal, senior consultant and chairman, department of medical oncology, Sir Ganga Ram Hospital, New Delhi. “But he was a smoker and consumed alcohol almost every evening. Both clear risk factors for CRC,” Dr Aggarwal says.

Here’s the good news and the bad news: CRC is a form of cancer that is heavily dependent on your lifestyle—your physical activity levels, your diet, how much you drink, and whether you smoke or not. Which means preventing it is largely in your hands.

“Yet its numbers are rising rapidly worldwide, and unfortunately in India too,” Dr Aggarwal says. The World Health Organization GLOBOCAN 2008 report, the latest study on this, says the estimated incidence level in India in 2008 was 36,476, and is expected to rise to 49,122 by 2013.

“CRC develops due to uncontrolled cell growth in the colon or rectum (parts of the large intestine) and the reasons that lead to it are rather straightforward,” explains Ashok Vaid, chairman, division of medical and paediatric oncology, haematology and bone marrow/stem cell transplant, Medanta–The Medicity, Gurgaon. “While there is some genetic component, close relatives like parents, brothers, sisters, or children of a person with a history of colon cancer are somewhat more likely to develop this disease themselves, especially if the relative had the cancer at a young age. But it’s mainly related to changing lifestyles and eating habits.”

A diet low in fibre and vegetables is one of the leading culprits.

A diet low in fibre and vegetables is one of the leading culpritsAccording to Rajinder Kaur Saggu, consultant surgical oncologist, Indraprastha Apollo Hospital, New Delhi, CRC was the third most common cancer worldwide in men (663,904 cases, 10% of the total cancers) and the second in women (571,204 cases, 9.4% of the total cases) in 2008.

“The original Indian meal, which is naturally high on fibre, ensured people didn’t get colon cancer,” says Dr Saggu. “Deviating from the Indian cereal-based diet and adopting a Western diet that is more focused on preservatives-laden, low-fibre junk is proving disastrous for our health,” she says. The average Indian diet is heavy in vegetables, pulses and wholegrain like atta.

In India, CRC ranks as the sixth most common cancer across age groups. “This is probably because of the traditionally vegetarian diet that we consume,” says Dr Vaid. “But in recent years this has undergone a massive change, and now we see many more cases of CRC coming up. As per WHO GLOBOCAN, in India, 42,000 cases are expected to be diagnosed in 2012.”

Diet demons
Diets high in vegetables, fruits and wholegrains are a clear safeguard, and linked to a decreased risk of colorectal cancer. According to the study, Fruit, Vegetables, Dietary Fiber, And Risk of Colorectal Cancer by Paul Terry, et al, published in the Journal of National Cancer Institute in 2001, some clinical trials show that cereals, especially wheat bran, contain substances such as fibre, phytic acid, various phenolic compounds, lignins, and flavonoids that might lower the risk for colorectal cancer.

On the other hand, diets that contain a lot of animal fat and red meat, especially processed meats like ham, sausages or bacon, can increase the risk of developing bowel cancer.

“The greatest increase in risk seems to be for people eating two or more portions of red or processed meat a day,” says Dr Saggu. “No link has been found between eating poultry such as turkey and chicken, and an increased risk of this cancer.”

A study published in the February 2007 edition of the International Journal of Cancer states that there is a 15% increase in risk of colon or rectal cancer with an increase of 100g of alcohol intake per week. The study adds that high alcohol intake was significantly associated with increased risk of colon and rectal cancer.

“The more you drink, the more the risk increases,” says Dr Aggarwal. “This may be due to the fact that heavy alcohol users tend to have low levels of folic acid in the body.”

Radheshyam Naik, head, medical oncology and stem cell transplantation at the HCG Bangalore Institute of Oncology Speciality Centre, Bangalore, explains further, “The carcinogenic effects of alcohol include immunodepression, activation of liver procarcinogens, and changes in bile composition, as well as increased tissue nitrosamine levels (due to nitrosamine content of alcoholic beverages).”

Other factors
The cancer is also more common in people who have smoked cigarettes for a long time (20 years or more, says Dr Saggu). “Smoking is a well-known cause of lung cancer, but some of the carcinogens in smoke dissolve in saliva and if swallowed, can cause digestive system cancers like colorectal cancer,” says Dr Saggu.
Being overweight and inactive also seems to be a risk factor for this cancer, and raises the probability of developing the disease in both men and women, though the link is stronger in men.

“People who have had ulcerative colitis disease (disease of the lining of the bowel) for a long time also have an increased risk of developing bowel cancer,” says Dr Saggu. “Individuals with a history of diabetes or frequent constipation are also at an increased risk for this cancer.”

Easy detection
Despite its high incidence, colon cancer is one of the most easily detectable and, if found early enough, also one of the most treatable forms of cancer.

“This is one cancer that awareness alone can help beat. The problem is that its symptoms are often confused with haemorrhoids, piles or even irritable bowel syndrome, leading to late detection,” says Dr Aggarwal. “That is why screening can save lives. It can find precancerous polyp (abnormal growths in the colon or rectum) so that they can be removed before turning into cancer, and also help catch the cancer at an early stage, when treatment usually leads to a cure.”

The probability of a cure decreases from 90% in the first stage to 30% in the terminal stage (stage 4), according to the experts interviewed. They recommend that people over 40 years be screened regularly for this.

“Colorectal cancer initially starts in the lining of the bowel and if left untreated, can grow into the muscle layers underneath, and then through the bowel wall,” says Dr Saggu, adding, “Cancers that are confined within the wall of the colon are often curable with surgery.”

Modern technology ensures that less than 5% of all colorectal cancer patients require a colostomy, the surgical construction of an artificial excretory opening from the colon, according to Dr Aggarwal.

Stay alert
While some of these symptoms seem like commonplace ailments, see a doctor if they recur often, in combination, or are persistent problems.

  • Diarrhoea or constipation lasting more than two weeks, blood or mucous in stool
  • Pencil stools (thinner than usual) or feeling as if you cannot empty your bowels completely
  • Anaemia
  • Abdominal swelling or persistent abdominal pain or discomfort
  • Unexplained weight loss
  • Extreme tiredness, or a dizzy feeling
  • Flatulence
  • Vomiting

The tests
The high-sensitivity faecal occult blood test (FOBT), which checks for hidden blood in three consecutive stool samples, should be done every year.

Flexible sigmoidoscopy, where doctors use a flexible, lighted tube (sigmoidoscope) to look at the interior walls of the rectum and part of the colon, should be done every five years.

Colonoscopy, where physicians use a flexible, lighted tube (colonoscope) to look at the interior walls of the rectum and the entire colon (during this procedure, samples of tissue may be collected for closer examination, or polyps may be removed), should be done every 10 years.

Source: LiveMint

 
Leave a comment

Posted by on November 7, 2012 in Wellness

 

Tags: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , ,

European Society Of Medical Oncology (ESMO) In Collaboration With Apollo Cancer Institute, Chennai Rolls Out First Colorectal Cancer Education Program In India To Share Global Treatment Strategies

  • Colorectal Cancer (CRC) is the 6th most prevalent cancer in India – Globocan 2008
  • Personalized treatment for CRC can improve overall long-term outcomes for patients
  • Leading Oncologists across South India participated in the program

Chennai April 21, 2012: Colorectal Cancer is the sixth most prevalent cancer in India, with an estimated 41,535 patients in 2011. With the objective to create a platform for dialogue, best practice sharing and education, Apollo Cancer Institute, Chennai in collaboration with European Society for Medical Oncology (ESMO) organized the ESMO Asia CME Program on Colorectal Cancer at the Hyatt Regency today. This scientific initiative is supported by Merck Serono – the biopharmaceutical division of Merck KGaA, Darmstadt, Germany, a global pharmaceutical and chemical company.

This is the first of its kind of a partnership by ESMO with Indian Oncology Hospitals on providing oncology education in Colorectal Cancer. The collaboration sees the establishment of a new, world-class medical education platform that will give oncologists access to the latest scientific knowledge and information on patient-centric care strategies, with the aim of improving care for colorectal cancer patients at every stage of their treatment journey. Chennai is the third city where the program has been rolled out, first two being Delhi and Mumbai.

As per Globocan 2008, the projected incidence for Colorectal Cancer in India is 44,508 cases by 2015. Worldwide approximately one million patients suffer from this disease.

‘Personalized Treatment for Colorectal Cancer’ was one of the key topics of discussion. Noted oncologist, Prof. Claus – Henning Kohne, Director of Klinik for Oncology and Hematology (Germany) and Dr. T Raja, Program Director, Apollo Cancer Institute, Chennai, an ESMO ASIS CME Partner Centre shared information on principles of diagnostics and staging of colorectal cancer, adjuvant treatment for colon cancer and management of metastatic colorectal cancer. The program provided an East meets West platform for knowledge sharing and collaborations among oncology professionals in Europe and Asia. It promotes Continuing Medical Education (CME) in colorectal cancer management in oncologists, thereby ensuring high quality cancer care to be provided to patients.

Speaking at the occasion, Prof. Claus-Henning Kohne, Director of Klinik for Oncology and Hematology (Germany) said, “The ESMO ASIA education initiative is unique because it brings together all of the medical experts involved in treating the patient and draws upon their specific experience at each stage in the delivery of treatment. This multi-disciplinary approach is part of a broader move to develop more patient-centric treatment strategies in order to improve both the patient’s quality of care and quality of life. In 2012, ESMO ASIA plans to establish further educational platforms across the region with a localised curriculum for each country.”

Dr. T Raja, Program Director, Apollo Cancer Institute, Chennai elaborated upon the problem of Colorectal Cancer in India that requires much attention. Addressing the eminent group of oncologists, he said, “Colorectal Cancers needs multidisciplinary management to achieve better outcome in these patients He further stressed upon to deliberate on the recent treatment advances in this field and its application in Indian Scenario.”

Colorectal cancer (CRC) – also commonly called bowel cancer – is a disease in which malignant cells grow in the tissue of the colon or rectum, forming tumors. In the early stages of CRC, surgery alone may be curative. However, symptoms of CRC are often vague and – despite it being one of the most common cancers worldwide – public awareness of the disease is low. As a result, one in four patients is diagnosed when the cancer has already spread (metastasized), via the bloodstream and lymph nodes in the bowel, to other organs in the body. This advanced stage of the disease, which is known as metastatic colorectal cancer (mCRC), is difficult to treat and is associated with low survival rates.

The latest research demonstrates that Personalized Treatment for CRC by identification of specific molecules (also called ‘biomarkers’) can help physicians identify which patients are most likely to benefit from a specific treatment. This breakthrough enables oncologists to select the most appropriate treatment for patients from the point of diagnosis and thus improves their overall long-term outcomes.

About The European Society for Medical Oncology (ESMO)
The European Society for Medical Oncology (ESMO) is the leading European professional organization, committed to advancing the specialty of medical oncology and promoting a multidisciplinary approach to cancer treatment and care. Since its founding in 1975 as a non-profit organization, ESMO’s mission has been to advance cancer care and cure. This is achieved through fostering and disseminating good science that leads to better medicine and determines best practice.

 
1 Comment

Posted by on April 22, 2012 in Industry, Merck Serono

 

Tags: , , , , , , , , , , , , , , , , , , , , , ,